Citadel Advisors’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Citadel Advisors’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-35,544	Closed	-$175K	–	15042
2021 Q4	$306K	Sell	35,544 -15,838	-31%	-$101K	﹤0.01%	10877
2021 Q3	$391K	Buy	+51,382	New	+$433K	﹤0.01%	10464
2021 Q2	–	Sell	-16,120	Closed	-$102K	–	14729
2021 Q1	$195K	Buy	+16,120	New	+$320K	﹤0.01%	11737

Other funds holding LHDX

Eclipse Ventures Palo Alto, California $2.57B AUM

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

CWA

Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors's LHDX Position: Q1 2022 in Review

Citadel Advisors sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2022, closing a stake of 35,544 shares — an estimated $175K sold.

Citadel Advisors first reported a position in LHDX in Q1 2021 and held it in 3 quarters. The position peaked at $391K in Q3 2021. 40 funds tracked by Wall St. Rank hold LHDX as of Q1 2022.

Citadel Advisors reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Citadel Advisors sold 35,544 Lucira Health, Inc. Common Stock shares in Q1 2022, an estimated $175K.
Citadel Advisors first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Citadel Advisors's Lucira Health, Inc. Common Stock position peaked at $391K in Q3 2021.
40 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.